Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA

Conventional chemotherapy is plagued with adverse side effects because cancer treatments are subject to numerous variations, most predominantly from drug resistance. Accordingly, multiple or multistage chemotherapeutic regimens are often performed, combining two or more drugs with orthogonal and pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Hong Yeol, Son, Sejin, Lee, So Jin, You, Dong Gil, Yhee, Ji Young, Park, Jae Hyung, Swierczewska, Maggie, Lee, Seulki, Kwon, Ick Chan, Kim, Sun Hwa, Kim, Kwangmeyung, Pomper, Martin G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217108/
https://www.ncbi.nlm.nih.gov/pubmed/25363213
http://dx.doi.org/10.1038/srep06878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217108/
https://www.ncbi.nlm.nih.gov/pubmed/25363213
http://dx.doi.org/10.1038/srep06878

Ejemplares similares